Digirad

$2.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.36 (+15.32%) Today
+$0.09 (+3.32%) As of 6:34 AM EST after-hours

Why Robinhood?

You can buy or sell Digirad and other stocks, options, and ETFs commission-free!

About DRAD

Digirad Corp. engages in the provision of healthcare solutions. It operates through the following segments: Diagnostic Services, Mobile Healthcare, Diagnostic Imaging, Building and Construction and Real Estate and Investments. The Diagnostic Services segment offers imaging and monitoring services program for purchasing equipment or outsourcing the procedures to another physician or imaging center. The Mobile Healthcare segment provides contract diagnostic imaging, including computerized tomography, magnetic resonance imaging, positron emission tomography, PET/CT and nuclear medicine and healthcare to hospitals, delivery networks and federal institutions on a long-term contract basis, as well as provisional services to institutions that are in transition. The Diagnostic Imaging segment sells internally developed solid-state gamma cameras, imaging systems and camera maintenance contracts. The Building and Construction segment provides residential and commercial construction projects by manufacturing modular housing units and other products and supplies general contractors with building materials. The Real Estate and Investments segment manages real estate assets and investments. The company was founded in 1997 and is headquartered in Suwanee, GA. The listed name for DRAD is Digirad Corporation Common Stock.

CEO
Matthew Gabel Molchan
Employees
618
Headquarters
Suwanee, Georgia
Founded
1997
Market Cap
12.90M
Price-Earnings Ratio
Dividend Yield
Average Volume
463.33K
High Today
$2.79
Low Today
$2.38
Open Price
$2.44
Volume
1.09M
52 Week High
$8.84
52 Week Low
$1.99

Collections

DRAD Earnings

-$1.42
-$0.85
-$0.27
$0.30
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
per share
Actual
Available Nov 13, Pre-Market

You May Also Like